The Scientist

» drug development

Most Recent

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

0 Comments

image: Experimental MERS Treatments Target Host Cell Receptor

Experimental MERS Treatments Target Host Cell Receptor

By Ashley Yeager | March 30, 2017

Researchers are searching for ways to prevent the coronavirus from attaching to DPP-4 receptors, blocking it from invading and replicating within host cells.

0 Comments

image: Tetracycline Inventor Dies

Tetracycline Inventor Dies

By Kerry Grens | March 15, 2017

Lloyd Conover, a longtime chemist at Pfizer, pioneered the concept of chemically altering natural antibiotics to create new drugs.

0 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By John D. Loike and Jennifer Miller | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Infographic: The Cost of Drug Development

Infographic: The Cost of Drug Development

By John D. Loike and Jennifer Miller | February 1, 2017

Expensive clinical trials and few drug approvals can drive up drug prices for consumers.

0 Comments

image: Pitcher Plant Enzymes Digest Gluten in Mouse Model

Pitcher Plant Enzymes Digest Gluten in Mouse Model

By Jenny Rood | February 1, 2017

A newly discovered protease could break down grain proteins that trigger celiac disease.

0 Comments

image: Califf Vacates FDA’s Top Post

Califf Vacates FDA’s Top Post

By Bob Grant | January 20, 2017

Robert Califf steps down as FDA Commissioner as Donald Trump takes office.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By Kerry Grens | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Pharma Redo

Pharma Redo

By The Scientist Staff | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By Anna Azvolinsky | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

Popular Now

  1. Sci-Hub Loses Domains and Access to Some Web Services
  2. Nobel Prize–Winning Biologist Dies
  3. CDC: Flu Vaccine 36 Percent Effective So Far
  4. Stem Cell Vaccine Protects Mice From Cancer
AAAS